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We previously reported that leucine-rich repeat and ﬁbronectin type III domain-containing 4
(LRFN4) functioned in migration and morphological change (i.e.cell elongation) of monocytic cells.
Here, we examined a molecular mechanism regulating LRFN4-mediated cell elongation. We found
that 14-3-3 and NCK proteins complexed with LRFN4, and they were involved in LRFN4-mediated
cell elongation. We also identiﬁed the regions of LRFN4 interacting with NCK1 and 14-3-3s. Finally,
we demonstrated that a Rac1 small GTPase was involved in LRFN4-mediated cell elongation. These
results indicated that LRFN4 complexed with 14-3-3s and NCK1 to mediate elongation in monocytic
cells via Rac-1-mediated actin cytoskeleton reorganization.
Structure summary of protein interactions:
LRFN4 physically interacts with NCK1 and 14-3-3 gamma by anti tag coimmunoprecipitation (View
Interaction:1, 2, 3, 4, 5, 6, 7)
LRFN4 physically interacts with 14-3-3 gamma, 14-3-3 zeta/delta, 14-3-3 epsilon, 14-3-3 eta and 14-3-
3 theta by anti bait coimmunoprecipitation (View interaction)
LRFN4 physically interacts with UTRN, PTPN13, MPDZ, FASN, CAD, DDX1, CTNNAL1, MPP5, HSPA1A,
HSPA8, HSPA9, SNX27, PPP2R1A, GOPC, NCK1, NCK2, PRMT1,PPP2CA, PPP2CB, 14-3-3 epsilon, 14-3-
3 gamma, 14-3-3 zeta/delta, 14-3-3 theta, 14-3-3 eta and 14-3-3 beta/alpha by anti tag coimmunopre-
cipitation (View interaction)
LRFN4 physically interacts with 14-3-3 gamma and NCK1 by anti bait coimmunoprecipitation (View
interaction)
LRFN4 physically interacts with 14-3-3 gamma, 14-3-3 zeta/delta, 14-3-3 epsilon, 14-3-3 eta and 14-3-
3 theta by anti tag coimmunoprecipitation (View interaction)
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n.Monocytes and macrophages play important roles in immune
responses and in tissue remodeling and repair [1]. In response to
inﬂammation, circulating monocytes in blood vessels adhere to
and subsequently migrate into the endothelium, move into sites
of infected tissue, and then differentiate into a variety of tissue-res-
ident macrophages [1–6]. Although the mechanism of monocyte
migration is not fully understood, chemokine-mediated integrin
activation of monocytes and their subsequent ﬁrm adhesion to
the endothelium are essential events at the initial phase of trans-
endothelial migration [2–8]. After ﬁrm adhesion, monocytes
extend membrane protrusions into the endothelial cell bodieslsevier B.V. All rights reserved.
2252 S. Konakahara et al. / FEBS Letters 586 (2012) 2251–2259and endothelial cell junctions, and then migrate through the base-
ment membrane [6].
The leucine-rich repeat and ﬁbronectin type III domain-contain-
ing (LRFN) protein family comprises ﬁve type I transmembrane
glycoproteins, LRFN1–LRFN5 [9–14]. All members of the LRFN fam-
ily contain extracellular leucine-rich repeats, an immunoglobulin
C2-like domain, a ﬁbronectin type III domain, a transmembrane
domain, and a cytoplasmic C-terminal tail [9–14]. LRFN1, 2, and
4 each contain a C-terminal postsynaptic density 95 (PSD95)/discs
large/zona occludin-1 (PDZ)-binding domain; these PDZ-binding
domains play essential roles in cellular responses via association
with PDZ proteins [9–14]. Reportedly, the expression of LRFN fam-
ily members is largely restricted to neural tissue [9–14]. However,
we recently observed that LRFN4 is expressed in monocytic cells
and that LRFN4 expression in these cells is upregulated after
monocytes differentiate into macrophages [15]. We also demon-
strated that LRFN4 signaling mediates transendothelial migration
and morphological changes of monocytic cells via reorganization
of the actin cytoskeleton [15].
14-3-3 Proteins are adaptor molecules; these proteins are
highly conserved, 30-kDa proteins, and there are seven major iso-
forms, b=a; e;c;g; h=s;r, and f/d [16]. 14-3-3 Proteins speciﬁcally
bind to phosphoserine motif (RXXpS), and form homo- or hetero-
dimers [16,17]. 14-3-3 Proteins have large numbers of binding0 min
10 min
30 min
60 min
Nuclei LRFN4-GFP
Fig. 1. Stimulation with immobilized anti-LRFN4 mAb induces cell elongation of THP-1 c
were stimulated with immobilized anti-LRFN4 mAb for the indicated periods. The cells w
and observed using confocal laser scanning microscopy. Arrowheads in the image indicpartners, and they modulate a myriad of cellular processes, includ-
ing regulation of enzymatic activity, regulation of protein interac-
tions, apoptotic cell death, cell cycle control, cell migration, and
actin cytoskeleton reorganization [16,18–21].
NCK proteins (NCK1 and NCK2) are adaptor molecules that con-
tain three Src-homology 3 (SH3) domains and one SH2 domain
[22]. The SH2 domain of NCK proteins can bind cell surface recep-
tors, and the NCK SH3 domains can bind downstream effectors
thereby linking receptors to effectors [22]; NCK proteins regulate
numerous cellular processes, including DNA synthesis, transcrip-
tion, translation, protein degradation, and actin cytoskeleton reor-
ganization [22–26].
The Rho family small GTPases, including RhoA, Rac1, and Cdc42,
play essential roles in actin cytoskeleton reorganization [27–30].
During cell migration, each member of the Rho family small GTP-
ases has a distinct role [27–30]. At the leading edge of a migrating
cell, Rac1 and Rac1 effector molecules play central roles in lamel-
lipodia formation [23,26–30]. At the trailing edge of migrating cell,
RhoA and RhoA effector molecules regulate contractility and tail
retraction [27–30].
Here, we examined a molecular mechanism that regulated
LRFN4-mediated morphological changes, including lamellipodia
formation. We identiﬁed the proteins that complexed with LRFN4
and examined the involvement of these proteins in LRFN4F-actin Merged
ells via actin cytoskeleton reorganization. THP-1 cells expressing LRFN4-GFP (green)
ere stained with rhodamine-conjugated phalloidin (red) and Hoechst 33342 (blue),
ated the cells which formed typical lamellipodia. Scale bar, 10 lm.
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Fig. 2. LRFN4 complexes with 14-3-3s and NCKs. (A) Lysates of HEK293T cells expressing Myc-LRFN4-CT or empty vector (Mock) were subjected to immunoprecipitation
using anti-Myc mAb. Immunoprecipitated proteins were separated by SDS–PAGE, and proteins on the polyacrylamide gel were stained with a SYPRO Ruby Protein Gel Stain.
Bands enclosed within a rectangle were excised for protein identiﬁcation. 14-3-3s, and NCKs were identiﬁed from the regions 11–12, and 8, respectively. (B) Lysates of THP-1
cells expressing Myc-LRFN4-CT or empty vector (Mock) were subjected to immunoprecipitation using anti-Myc mAb and analyzed on immunoblots. (C) Lysate of THP-1 cells
expressing exogenous LRFN4 were subjected to immunoprecipitation using anti-LRFN4 mAb or control IgG, and immunoprecipitated proteins were analyzed on
immunoblots. (D) Lysate of THP-1 cells expressing LRFN4-GFP were subjected to immunoprecipitation using anti-GFP mAb or control IgG, and immunoprecipitated proteins
were analyzed on immunoblots.
S. Konakahara et al. / FEBS Letters 586 (2012) 2251–2259 2253signaling. We demonstrated that LRFN4 formed a complex with
14-3-3s and NCK1 to induce morphological change in monocytic
cells via Rac1-mediated actin cytoskeleton reorganization.
2. Materials and methods
2.1. Reagents and antibodies
The reagents and antibodies used in this study were as de-
scribed in Supplementary information (Section S2.1.).
2.2. Plasmid construction
The detailed methods of this section were as described in Sup-
plementary information (Section S2.2.).2.3. Cell culture
Cell culture was performed as described previously [15].
2.4. Using liquid chromatography (LC)-tandem mass spectrometry
(MS/MS) and database searches to identify proteins that complex with
the cytoplasmic region of LRFN4
The detailed method of this section was as described in Supple-
mentary information (Section S2.3.)
2.5. Retrovirus infection
Retrovirus infections were performed as described previously
[15].
2254 S. Konakahara et al. / FEBS Letters 586 (2012) 2251–22592.6. Immunoprecipitation
THP-1 cells expressing an LRFN4 mutant or an NCK1 mutant or
both were lysed in lysis buffer (50 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 1% NP-40, 10% Glycerol, 1.5 mM MgCl2, 1 mM EDTA, 1% Pro-
tease Inhibitor Cocktail) and incubated on ice for 30 min. For the
identiﬁcation of proteins binding to LRFN4 cytoplasmic region in
THP-1 cells, the supernatants were immunoprecipitated using c-
Myc tagged protein mild puriﬁcation kit according to the manufac-
turer’s instructions. For analysis of the effect of LRFN4mutations or
NCK1 mutations on LRFN4-14-3-3s-NCK1 complex formation, the
supernatants were incubated with 5 lg of an anti-FLAG mAb
(clone M2, used as a negative control), anti-GFP mAb (clone
mFX73), or anti-LRFN4 mAb (clone 3A12-7) for 2 h, followed by
an 1-h incubation with 50 ll of TrueBlot Anti-Mouse Ig IP Beads.
The beads were washed three times with lysis buffer, and the
bound immunocomplexes were eluted from the beads with SDS–
PAGE sample buffer.
2.7. Immunoblotting
The cell lysates and immunoprecipitated proteins were sepa-
rated by SDS–PAGE and transferred onto PVDF membranes. The
membranes were blocked with 5% non-fat drymilk in PBS contain-
ing 0.05% Tween-20 (PBST) for 1 h at room temperature. These
membranes then were incubated with appropriate primary
antibodies over night at 4 C. After washing in PBST, the mem-
branes were incubated with appropriate secondary antibodies for
2 h at room temperature. Immunoreactive protein bands wereTable 1
Identiﬁcation of the proteins that complex with Myc-LRFN4 CT.a
Slice no. Approx. mass (kDa)
(number of the detected
bands)
UniProt
accession
Protein name
1 >200 (1) P46939 Utrophin
2 >200 (2) Q12923 Tyrosine-protein phosphatase no
receptor type 13
O75970 Multiple PDZ domain protein
3 >200 (2) P49327 Fatty acid synthase
P27708 CAD protein
4 70–90 (3) Q92499 ATP-dependent RNA helicase DD
Q9UBT7 Alpha-catulin
Q8N3R9 MAGUK p55 subfamily member
5 60–70 (3) P08107 Heat shock 70 kDa protein 1
P11142 Heat shock cognate 71 kDa prot
P38646 Stress-70 protein, mitochondrial
6 60 (2) Q96L92 Sorting nexin-27
P30153 Serine/threonine-protein phosph
2A 65 kDa regulatory subunit A
isoform
7 55 (1) Q9HD26 Golgi-associated PDZ and coiled
motif-containing protein
8 45 (2) P16333 Cytoplasmic protein NCK1
O43639 Cytoplasmic protein NCK2
9 40 (1) Q99873 Protein arginine N-methyltransf
10 35 (1) P67775 Serine/threonine-protein phosph
2A catalytic subunit alpha isofor
P62714 Serine/threonine-protein phosph
2A catalytic subunit beta isoform
11 33 (1) P62258 14-3-3 protein epsilon
12 31 (1) P61981 14-3-3 protein gamma
P63104 14-3-3 protein zeta/delta
P27348 14-3-3 protein theta
Q04917 14-3-3 protein eta
P31946 14-3-3 protein beta/alpha
a This table shows the protein identiﬁcations arranged in order of the sequence covera
and 12, each containing a single band, exceptionally more than two protein isoforms ar
b Deduced from the sequence of a matured protein (http://expasy.org/tools/pi_tool.ht
c Residue numbers in the unprocessed precursor sequence.
d Mascot peptide ion score more than 40.
e Ratio of the peptide assignments to the matured protein as the number of amino acvisualized using Immobilon Western Chemiluminescent HRP
Substrate according to the manufacturer’s instructions. Images
were acquired with a LAS-4000 mini (Fujiﬁlm, Tokyo, Japan). The
antibodies used in this study were as follow: mouse anti-c-Myc
mAb (1:1000 dilution, clone 9E10), mouse anti-14-3-3c mAb
(1:10000 dilution, clone KC21), rabbit anti-NCK1 pAb (1:5000 dilu-
tion), mouse anti-LRFN4 mAb (1 lg/ml, clone 3A12-7), mouse anti-
GFP mAb (1:1000 dilution, clone mFX75), mouse TrueBlot ULTRA
(1:5000 dilution), and rabbit TrueBlot (1:5000 dilution).
2.8. Cell elongation assay
Cell elongation assays were performed as described previously
[15]. Brieﬂy, 15-mm u glass coverslips (Matsunami Glass Indus-
tries, Osaka, Japan) were coated with 10 lg/ml of anti-LRFN4
mAb (clone 3A12-7) over night at 4 C; unbound antibodies were
then washed out with RPMI-1640 medium supplemented with
10% FBS. For analysis of the effect of LRFN4 or NCK1 mutants,
THP-1 cells expressing these mutants (1 105 cells/coverslip)
were seeded onto anti-LRFN4 mAb-coated coverslips. For analysis
of the effect of Rac1 inhibitor II or Y-27632, THP-1 cells expressing
LRFN4-GFP (1 105 cells/coverslip) were pre-treated with differ-
ent concentrations of the inhibitors (Rac1 inhibitor II: for 4 h, Y-
27632: for 30 min) and then seeded onto anti-LRFN4 mAb-coated
coverslips. After a speciﬁed incubation time, cells were ﬁxed and
the ratio of elongated cells to total adherent cells was calculated
based on microscopic observations and cell counts, as described
previously [15]; elongated cells were deﬁned as cells with protru-
sions that were at least twice as long as the width of the cell body.Molecular
weightb
Extent of a
matured
proteinc
Number of
peptide
assignments d
Sequence
coverage
(%)e
Gene
name
394466 1-3433 17 8.4 UTRN
n- 276906 1-2485 24 12.6 PTPN13
218597 1-2042 18 11.0 MPDZ
273400 1-2511 30 14.3 FASN
242853 2-2225 18 11.1 CAD
X1 82432 1-740 26 33.2 DDX1
81896 1-734 15 27.4 CTNNAL1
5 77294 1-675 13 25.2 MPP5
70052 1-641 32 52.4 HSPA1A
ein 70898 1-646 39 47.7 HSPA8
68759 47-679 39 47.1 HSPA9
61265 1-541 36 59.5 SNX27
atase
alpha
65177 2-589 30 47.6 PPP2R1A
-coil 50520 1-462 31 60.8 GOPC
42864 1-377 15 44.3 NCK1
42915 1-380 13 40.8 NCK2
erase 1 41516 1-361 23 45.7 PRMT1
atase
m
35594 1-309 5 25.9 PPP2CA
atase 35575 1-309 5 25.9 PPP2CB
29174 1-255 63 75.7 YWHAE
28171 2-247 28 67.5 YWHAG
27745 1-245 29 65.7 YWHAZ
27764 1-245 41 63.3 YWHAQ
28088 2-246 27 62.4 YWHAH
27951 2-246 25 62.4 YWHAB
ge, as the same number as the protein bands detected in each slice. For Slice nos. 10
e listed with the highest sequence coverages.
ml).
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Fig. 3. The proline-rich SH3-binding region of LRFN4 is necessary both for the interaction between LRFN4 and NCK1 and for LRFN4-mediated elongation of THP-1 cells. (A)
Lysates of THP-1 cells expressing LRFN4 WT-GFP or D(571–580)-GFP were subjected to immunoprecipitation using anti-GFP mAb, and immunoprecipitated proteins were
analyzed on immunoblots. (B) THP-1 cells expressing LRFN4 WT-GFP or D(571–580)-GFP were stimulated with immobilized anti-LRFN4 mAb for 1 h. The ratio of elongated
cells in each sample was calculated. Data are presented as the mean  standard error. P < 0:005.
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Fig. 4. Ser 585 phosphorylation of LRFN4 is necessary both for LRFN4-14-3-3s-NCK1 complex formation and for LRFN4-mediated elongation of THP-1 cells. (A) Lysates of
THP-1 cells expressing LRFN4 WT-GFP, S585A-GFP, S610A-GFP, or 2SA-GFP were subjected to immunoprecipitation using anti-GFP mAb, and the immunoprecipitated
proteins were analyzed on immunoblots. (B) THP-1 cells expressing LRFN4 WT-GFP, S585A-GFP, S610A-GFP, or 2SA-GFP were stimulated with immobilized anti-LRFN4 mAb
for 1 h. The ratio of elongated cells in each sample was calculated. Data are presented as the mean  standard error. P < 0:005; P < 0:0005.
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reliability of data.
2.9. Fluorescent microscopy
Fluorescent microscopic observations were performed as de-
scribed previously [15].
3. Results
3.1. LRFN4 signaling induces cell elongation of monocytic cells via
actin cytoskeleton reorganization
We previously demonstrated that stimulation of monocytic
THP-1 cells expressing exogenous LRFN4 protein or LRFN4-GFP fu-
sion protein with immobilized anti-LRFN4 monoclonal antibodies(mAbs) induced cell elongation via actin cytoskeleton reorganiza-
tion [15]. Here, we observed in more detailed the features of this
actin cytoskeleton reorganization during LRFN4-mediated elonga-
tion of THP-1 cells. In this experiment, we used THP-1 cells
expressing LRFN4-GFP fusion protein. LRFN4-GFP expression in
THP-1 cells was seven times higher than that in untransfected
THP-1 cells, and was 2.3 times higher than that in macrophage-dif-
ferentiated THP-1 cells ([15] and our unpublished data, respec-
tively. Both were demonstrated by ﬂowcytometry analyses). We
thought that examination of colocalization between ﬁlamentous
actin (F-actin) and LRFN4-GFP would be confusing because the en-
tire surface of each coverslip was coated with anti-LRFN4 mAbs.
Thus, we used GFP ﬂuorescence images just for the identiﬁcation
of THP-1 cells. Without stimulation, F-actin mainly localized at
the surface of THP-1 cells (Fig. 1, 0 min). During the initial phase
of stimulation, cells became ﬂattened, and membrane rufﬂes were
A
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2256 S. Konakahara et al. / FEBS Letters 586 (2012) 2251–2259observed (Fig. 1, 10 min). During the intermediate phase, cells be-
came elongated, and actin-rich lamellipodia were observed (Fig. 1,
30 min, arrowheads). Finally, lamellipodia were rarely observed
when the cells were highly elongated (Fig. 1, 60 min). These results
indicated that LRFN4 signaling induced actin cytoskeleton reorga-
nization and the formation of membrane rufﬂes and lamellipodia.
3.2. Identiﬁcation of the proteins that complex with LRFN4
We previously reported that overexpression of an LRFN4 mu-
tant lacking the cytoplasmic region (LRFN4 DCT) did not induce
elongation of THP-1 cells [15]. Thus we hypothesized that the pro-
teins interacting with LRFN4 cytoplasmic region (LRFN4-CT) might
regulate LRFN4-mediated elongation of THP-1 cells. Based on this
hypothesis, we performed a protein interaction assay. Proteins
were immunoprecipitated with anti-Myc mAb from lysate of
HEK293T cells that expressed Myc-LRFN4-CT and then separated
by SDS–PAGE; the protein bands on the polyacrylamide gel
(Fig. 2A) were identiﬁed using liquid chromatography (LC)-tandem
mass spectrometry (MS/MS) and database searches. The proteins
that complexed with Myc-LRFN4-CT were listed in Table 1. Several
types of proteins were identiﬁed, including PDZ proteins, adaptor
molecules, and enzymes. We chose to focus on two types of adap-
tor molecules, 14-3-3s and NCKs, in this study. The details and
functional analyses of the other proteins will be discussed in sep-
arate papers. We next conﬁrmed the protein–protein interaction
in THP-1 cells. When lysate of THP-1 cells expressing Myc-
LRFN4-CT was immunoprecipitated with anti-Myc mAb, 14-3-3
and NCK1 were co-precipitated (Fig. 2B). We also examined theinteraction of full-length LRFN4 with these proteins. Both exoge-
nous LRFN4 protein and LRFN4-GFP fusion protein interacted with
14-3-3s and NCK1 (Fig. 2C, D and S1). We also found that 14-3-3
and NCK1 proteins seemed to localize at lamellipodia in THP-1
cells during LRFN4-mediated elongation (Fig. S2).
3.3. Identifying LRFN4 regions that complex with NCK1 and 14-3-3
We next focused on identifying the regions of LRFN4 that com-
plexed with NCK1 and 14-3-3s. There is a proline-rich SH3 binding
motif in the LRFN4 cytoplasmic region ([RKY]XXPXXP; a.a. 574-
580), and NCK1 may interact with this region via its SH3 domain.
To evaluate this hypothesis, we generated THP-1 cells that ex-
pressed a mutant LRFN4-GFP fusion protein, LRFN4 D(571–580)-
GFP, lacking the region around the SH3 binding motif. When this
LRFN4 mutant was immunoprecipitated from lysate of these
THP-1 cells with anti-GFP mAb, NCK1 was not co-precipitated
(Fig. 3A). We also found that overexpression of LRFN4 D(571–
580)-GFP in THP-1 cells inhibited LRFN4-mediated elongation
(Fig. 3B). There are two 14-3-3 binding motifs in the LRFN4 cyto-
plasmic region (RXXpS; a.a. 582–585 and a.a. 607–610); therefore,
14-3-3s may interact with these phosphorylated serine residues.
To evaluate this hypothesis, we generated THP-1 cells that ex-
pressed a S585A, S610A, or S585A/S610A (2SA) mutant LRFN4-
GFP fusion protein. Co-immunoprecipitation analysis revealed that
the S585A and 2SA LRFN4-GFP mutants did not co-precipitate 14-
3-3s (Fig. 4A), and overexpression of the S585A or 2SA mutant in
THP-1 cells inhibited LRFN4-mediated elongation (Fig. 4B). Sur-
prisingly, neither the S585A nor the 2SA LRFN4-GFP mutant co-
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immobilized anti-LRFN4 mAb for 1 h. The ratio of elongated cells in each sample was calculated. Data are presented as the mean  standard error. (C) THP-1 cells expressing
LRFN4-GFP were pre-treated with 50 lM of Rac1 inhibitor II or 10 lM of Y-27632, and then stimulated with immobilized anti-LRFN4 mAb for 1 h. The cells were stained with
rhodamine-conjugated phalloidin and observed using ﬂuorescent microscopy. Scale bar, 20 lm.
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residues were involved in LRFN4-14-3-3s-NCK1 complex forma-
tion (Fig. 4A). We also generated a series of sequential deletion
mutations that covered the entire LRFN4 cytoplasmic region
(Fig. S3A), and co-immunoprecipitation of these mutants con-
ﬁrmed that LRFN4-14-3-3s-NCK1 complex formation was depen-
dent on the region between a.a. 571 and a.a. 590 in LRFN4
(Fig. S3B).
3.4. LRFN4-14-3-3s-NCK1 complex formation is involved in LRFN4-
mediated elongation of THP-1 cells
NCK1 has three SH3 domains and one SH2 domain [22]. It is
generally accepted that various intracellular signaling molecules
and transmembrane proteins bind to these NCK1 domains [22].
We generated THP-1 cells that expressed individual NCK1 mutants
that lacked the SH3–1, SH3–2, SH3–3, or SH2 domains, and then
examined the effects of these deletions on LRFN4–NCK1 interac-
tions (Fig. 5A). Co-immunoprecipitation analysis revealed that
LRFN4 bound to the SH3-2 domain of NCK1 (Fig. 5B). There is a
14-3-3 binding motif between the SH3-1 and SH3-2 domains of
NCK1 (RXXpS; a.a. 82-85), and 14-3-3s may bind to this phosphor-
ylated serine residue. Interestingly, LRFN4-14-3-3s-NCK1 complex
formation was reduced in THP-1 cells expressing NCK1 S85A mu-
tant, indicating that NCK1 also bound to 14-3-3s through its phos-
phorylated-Ser 85 (Fig. 5B). We also performed cell elongation
assays using THP-1 cells that expressed individual NCK1 mutants,
and found that overexpression of the NCK1 DSH3-1, DSH3-2, DSH2,
or S85A mutant inhibited LRFN4-mediated elongation of THP-1cells (Fig. 5C). These results indicated that LRFN4-14-3-3s-NCK1
complex formation played a role in LRFN4-mediated elongation
of THP-1 cells, including lamellipodia formation. The results also
included the possibility that other proteins binding to SH3-1 or
SH2 domains of NCK1 were involved in LRFN4-mediated elonga-
tion of THP-1 cells.
3.5. Rac1 is involved in LRFN4-mediated elongation of THP-1 cells
LRFN4-mediated elongation of THP-1 cells induced actin cyto-
skeleton reorganization and related processes, including mem-
brane rufﬂing and lamellipodia formation (Fig. 1). Formation of
these actin-rich structures are often regulated by Rac1 [27–30],
and some Rac1 effector molecules such as p21/Cdc42/Rac1-acti-
vated kinases (PAKs) and Wiskott-aldrich syndrome protein family
verprolin homology domain-containing (WAVE) bind to SH3 do-
mains of NCK1 [22–24]. Furthermore, LRFN4-mediated elongation,
including lamellipodia formation, was inhibited in THP-1 cells
expressing the NCK1 DSH3-1 mutant, and this mutant exhibited
a weak inﬂuence on the LRFN4-14-3-3s-NCK1 interaction (Fig. 5B
and C). Based on these ﬁndings, we examined the involvement of
Rac1 in LRFN4-mediated elongation of THP-1 cells. We found that
pretreatment of THP-1 cells with Rac1 inhibitor II inhibited cell
elongation in a dose-dependent manner (Fig. 6A). Moreover, lamel-
lipodia formation was reduced in THP-1 cells treated with Rac1
inhibitor II (Fig. 6C). In contrast, when THP-1 cells were pretreated
with Y-27632, a speciﬁc inhibitor for ROCK (downstream effector
molecule of RhoA), cell elongation was rarely inhibited, regardless
of Y-27632 concentration, and elongation was occasionally en-
LRFN4
SH3-3 SH2
Ser585P
P
SH
3-
1
Ser85 NCK1
14-3-3s
Actin Cytoskeleton Reorganization
Cell Elongation/Migration
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SH3-2
Fig. 7. A schematic depiction of a model of the complex formed by LRFN4, 14-3-3s, and NCK1 and the events downstream of the formation or activation of that complex. The
more detailed explanation was as described in Discussion section.
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when THP-1 cells were pretreated with high concentrations of Y-
27632 (10–50 lM), cells became enlarged but lamellipodia forma-
tion were rarely inhibited (Fig. 6C). These results indicated that
processes dependent on actin cytoskeleton reorganization, espe-
cially lamellipodia formation, were regulated by the Rac1 cascade
during LRFN4-mediated elongation of THP-1 cells. The results also
suggested that RhoA-ROCK cascade regulated cellular contractility
and tension during LRFN4-mediated elongation of THP-1 cells.
4. Discussion
In the present study, we examined a molecular mechanism reg-
ulating LRFN4-mediated morphological changes, including lamelli-
podia formation. We identiﬁed the proteins that complexed with
LRFN4, 14-3-3 and NCK1 proteins. We demonstrated that LRFN4
formed a complex with these proteins to induce morphological
change in monocytic cells via Rac1-mediated actin cytoskeleton
reorganization.
During transendothelial migration of monocytic cells, integrin
family members and other membrane proteins play important
roles in adhesion to and subsequently migration into the endothe-
lium [2–6]. Stimulation with immobilized anti-LRFN4mAb induces
elongation of THP-1 cells without any other stimulation; therefore,
we have suggested that the signaling cascade associated with
LRFN4-mediated transendothelial migration and morphological
change might be independent of the integrin-dependent signaling
pathways [15]. However, our results from the present study indi-
cate that an unidentiﬁed membrane protein that interacts with
the SH2 domain of NCK1 may be involved in LRFN4 signaling. Thus,we postulate that LRFN4 signaling may affect the signaling of inte-
grin or other membrane proteins during transendothelial migra-
tion and morphological change of monocytic cells.
Although very few proteins have been identiﬁed that bind to
LRFN family proteins, PDZ proteins, such as PSD95, interact with
the PDZ-binding domain of LRFN family proteins and play essential
roles in neurite outgrowth and synapse formation [9–14]. We pre-
viously compared the elongation ratio of THP-1 cells expressing
exogenous LRFN4-GFP with that of THP-1 cells expressing exoge-
nous LRFN4, and there was no difference in the elongation ratio be-
tween these cells [15]. This result indicates either that the C-
terminal GFP tag does not disrupt the function of the C-terminal
PDZ-binding domain of LRFN4 or that the C-terminal PDZ-binding
domain is not involved in the elongation of THP-1 cells. Further-
more, here, we identiﬁed two types of adaptor proteins that com-
plexed with LRFN4, 14-3-3s and NCKs, and neither type had PDZ
domains; moreover, both proteins were involved in LRFN4-medi-
ated elongation of THP-1 cells. We cannot conclude that the C-ter-
minal PDZ-binding domain of LRFN4 is not involved in LRFN4-
mediated elongation of THP-1 cells, but there may be a signaling
cascade regulating LRFN4-mediated elongation of THP-1 cells that
is independent of PDZ proteins. Our data also indicated that other
molecules that bind to LRFN4-CT may be involved in LRFN4 signal-
ing, and we expect that the LRFN4-CT-interacting proteins that
were identiﬁed using LC–MS/MS and database searches (listed in
Table 1) are such candidate signaling molecules.
There are seven 14-3-3 isoforms; and these can form homo- and
hetero-dimers [16,17]. LRFN4 co-precipitated ﬁve – 14-3-3 e, c, g,
h/s, and f/d – of these isoforms. It is unclear whether the 14-3-3
proteins in LRFN4-14-3-3s-NCK1 complex form homo-or hetero-
S. Konakahara et al. / FEBS Letters 586 (2012) 2251–2259 2259dimers; both dimer types may be involved in LRFN4-mediated
elongation of THP-1 cells. 14-3-3 Proteins bind to phosphoserine
motifs, RXXpS [16,17]. Proteome analyses using mass spectrometry
indicated that Ser 585 of LRFN4 and Ser 85 of NCK1 were phos-
phorylated in HeLa cells during mitosis [31,32]; results from these
reports were consistent with our results. There may be unidenti-
ﬁed kinases and/or phosphatases that regulate the phosphoryla-
tion levels of these serine residues during LRFN4-mediated
elongation of THP-1 cells.
SH2 domain of NCK proteins can bind cell surface receptors, and
NCK SH3 domains can bind downstream effectors thereby linking
receptor to effector [22]. In contrast to results from previous studies
[22], our results demonstrated that LRFN4, which is a membrane
protein, might interact with the SH3-2 domain of NCK1. Our results
also indicated that the unidentiﬁed proteins that bind to the SH3-1
and SH2 domains of NCK1 may be involved in LRFN4 signaling.
During cell migration, spatiotemporal regulation of Rho family
small GTPase activity and the resulting actin cytoskeleton reorga-
nization are essential events [6,27–30]. Our results indicated that
Rac1 cascade and RhoA cascade have distinct roles in LRFN4-med-
iated cell elongation; this ﬁnding is consistent with ﬁndings from
previous studies; Rac1 cascade-mediated lamellipodia formation
at the leading edge and RhoA cascade-mediated tail retraction
[6,27–30]. Furthermore, our results also indicated that unidentiﬁed
Rac1 effector molecules, such as PAKs andWAVEs, may be involved
in LRFN4-mediated elongation of THP-1 cells via association with
the SH3 domains of NCK1.
In conclusion, we identiﬁed two types of adaptor proteins that
complexed with LRFN4 and demonstrated that these proteins regu-
lated morphological change of monocytic cells via Rac1; Fig. 7 is a
schematic diagram depicting amodel of this complex and its down-
stream effects. We found that 14-3-3 and NCK proteins interacted
with LRFN4 cytoplasmic region and that these proteins were in-
volved in LRFN4-mediated elongation of THP-1 cells. We also found
that the SH3-2 domain ofNCK1 interactedwith a proline-rich region
(a.a. 571–580 a.a.) of LRFN4, and that 14-3-3 dimers might bind to
both Ser 585-phosphorylated LRFN4 and Ser 85-phosphorylated
NCK1. Finally, we demonstrated that a Rho family small GTPase,
Rac1, was involved in LRFN4-mediated elongation of THP-1 cells.
These results indicated that LRFN4-mediatedmorphological change
of monocytic cells was regulated by 14-3-3s-NCK1 -Rac1-mediated
actin cytoskeleton reorganization. Further studies that explore the
relationship between LRFN4-14-3-3s-NCK1 complex formation
and Rac1 activation in LRFN4-mediated elongation of THP-1 cells
will provide valuable information for understanding the role of
LRFN4 in the regulation of monocyte/macrophage functions.
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